Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Stocks Mixed Ahead Of Johnson's Brexit Deal Vote

Fri, 20th Dec 2019 12:09

(Alliance News) - Stocks in London were mixed at midday on Friday as investors look ahead to the Brexit deal vote in Parliament in the afternoon, while the UK chancellor finally named a new governor of the Bank of England.

The FTSE 100 index was up 16.90 points, or 0.2% at 7,589.97. The mid-cap FTSE 250 index was down 60.96 points, or 0.3% at 21,605.18, and the AIM All-Share index was 0.4% higher at 941.63.

The Cboe UK 100 index was up 0.2% at 12,865.61. The Cboe 250 was 0.2% lower at 19,518.94, and the Cboe Small Companies was down 0.2% at 12,030.27.

In mainland Europe, the CAC 40 in Paris was up 0.5% and the DAX 30 in Frankfurt was up 0.6%.

"UK stocks are treading water as they eagerly await the next step in the Brexit process today. With Theresa May and Boris Johnson previously unable to pass their respective withdrawal agreements, the value of a strong parliamentary majority will become clear today as Johnson's deal looks set to sail through without a hitch. For markets this should provide some degree of certainty and confidence, yet we are instead seeing anxiety remain thanks to Johnson's hard deadline of December 2020 to conclude trade negotiations," said IG Group's Josh Mahony.

In the FTSE 100, AstraZeneca was up 1.5% after the Anglo-Swedish drugmaker said it divested the rights to cancer drugs Arimidex and Casodex in a number of countries to Juvise Pharmaceuticals for up to USD198 million.

At the other end of the large cap index, NMC Health was by far the worst performer, down 21%. The Financial Times on Friday reported the UAE-focused private healthcare firm held talks to raise EUR200 million of off-balance sheet debt to fund new hospitals.

NMC has come under increased scrutiny from analysts, investors and short-sellers this year about its apparent use of off-balance sheet financing, that does not count toward its official debt levels.

NMC shares dropped on Tuesday after short selling firm Muddy Waters Capital said it had shorted the stock, commenting: "We have serious doubts about the company's financial statements, including its asset values, cash balance, reported profit, and reported debt levels."

NMC on Thursday hit back saying the Muddy Waters report was "false" and "misleading".

NMC shares have almost halved in value this week.

Royal Dutch Shell 'A' and 'B' shares were down 1.2% on Friday, after the oil major guided for a potential impairment based on "the macro outlook".

Shell is to book a post-tax impairment of USD1.7 billion to USD2.3 billion for the fourth-quarter of 2019, based on macroeconomic conditions, without giving any further details. The oil giant, London's largest listed company by market capitalisation, guided for a number of other charges which are set to hit fourth-quarter earnings.

In the Upstream unit, Shell will book USD100 million to USD200 million in charges related to well write-offs, plus a USD500 million to USD600 million deferred tax charge. Production in the segment for the last quarter of 2019 is guided between 2.78 million and 2.83 million barrels of oil equivalent per day. Production in all of 2018 was around 2.7 million barrels a day.

Still to come in the UK corporate calendar, Anglo-US cruise line operator Carnival is expected to report annual earnings this afternoon.

The pound was quoted at USD1.3035 at midday, slightly higher than USD1.3015 late Thursday, after UK economic growth in the third-quarter was revised upwards, the Office for National Statistics revealed.

Third-quarter gross domestic product expanded 0.4% from the second quarter, the ONS said, having previously reported a quarter-on-quarter figure of 0.3%. The ONS also reported a higher annual growth figure, with GDP in the third quarter rising by 1.1% compared to the prior estimate of 1.0%. Services remain the main contributor to growth, the ONS said, with construction also contributing positively.

Meanwhile, the head of the UK financial watchdog Andrew Bailey has been chosen as the next governor of the Bank of England, the Treasury announced.

Bailey's tenure at the BoE will begin on March 16 next year and will succeed Canadian Mark Carney, who took up the role in 2013. Carney has since extended his tenure twice, the second time to avoid any disruption during the UK's talks to leave the EU.

Bailey has been head of the Financial Conduct Authority since July 2016. Before that, he was chief executive of the Prudential Regulation Authority.

As part of his general election pledge to have Brexit "decided" by Christmas, UK Prime Minister Boris Johnson will bring back the EU Withdrawal Agreement Bill for its second reading in the House of Commons on Friday.

After the Conservatives won a landslide at the general election and secured an 80-seat majority last week, the vote in the afternoon is expected to pass without a hitch for the government and lay the ground for a January exit from the EU.

The euro stood at USD1.1094 at midday, down from USD1.1111 late Thursday. Against the yen, the dollar was trading at JPY109.35, firm from JPY109.28 late Thursday.

Stocks in New York were set for a subdued open on Friday. All three major US stock indices set fresh highs on Thursday amid a cooling of US-China trade tensions and a new continental trade agreement among the US, Canada and Mexico advancing in Congress.

The DJIA was called called up 0.1%, the S&P 500 index called flat and the Nasdaq Composite up 0.1%.

Ahead in the economic events calendar, there are US third-quarter GDP figures at 1330 GMT.

Brent oil was quoted at USD66.22 a barrel at the equities close, soft against USD66.50 late Thursday.

Gold was quoted at USD1,477.30 an ounce at the London equities close, little changed USD1,476.20 late Thursday.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

London market Midday is available to subscribers as an email newsletter. Contact info@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more
19 Feb 2024 08:44

LONDON MARKET OPEN: Stocks drift; Currys surges on takeover interest

(Alliance News) - Stock prices in London were looking for direction early Monday, as investors weighed possible trajectories for US interest rate cuts and a China's economic recovery.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.